CytoDyn to Host Webcast to Provide Company Update
VANCOUVER, Washington, May 28, 2024 -- CytoDyn Inc. , a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that...
Source: marketscreener.com